| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.21 | 0.0002 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.79 | 0.002 |